CLINICAL_TRIALS
trial_result
· 2024-10-03
Clinical Trial Update: A Study to Assess the Safety, Tolerability, and Efficacy of IONIS-GHR-LRx Administered in Patients With Acromegaly [Phase 2]
Summary
Phase 2 study evaluating the safety, tolerability, and efficacy of IONIS-GHR-LRx in patients with acromegaly has completed enrollment with results posted in 202…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Ionis Pharmaceuticals, Inc. | Conditions: Acromegaly | Phase 2 | Status: COMPLETED | Results posted: 2024-10-03